Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share news the companies Asthma therapies Atectura and Enerzair will now be reimbursed by the Quebec and Nova Scotia governments. Saviuk telling Proactive this now means Enerzair and Atectura are now covered for more than 90% of privately covered lives across Canada.
Valeo Pharma’s Asthma therapies Enerzair and Atectura now publicly covered in Quebec and Nova Scotia
